Cite

HARVARD Citation

    Krell, D. et al. (2017). Audit of CA125 Follow-Up After First-Line Therapy for Ovarian Cancer. International journal of gynecological cancer. 27 (6), pp. 1118-1122. [Online]. 
  
Back to record